Considerations for Toxicology Studies of Respiratory Drug Products

By degeorge J.J.   Ahn C.H.   Andrews P.A.   Brower M.E.   Choi Y.S.   Chun M.Y.   Du T.   Lee-Ham D.Y.   McGuinn W.D.   Pei L.   Sancilio L.F.   Schmidt W.   Sheevers H.V.   Sun C.J.   Tripathi S.   Vogel W.M.   Whitehurst V.   Williams S.   Taylor A.S.  

Regulatory Toxicology and Pharmacology, Vol. 25, Iss. 2, 1997-04 ,pp. : 189-193

Academic Press

Access to resources Recommend Favorite

Pharmacokinetic Considerations in Clinical Toxicology: Clinical Applications

By Roberts Darren M.   Buckley Nick A.  

Clinical Pharmacokinetics, Vol. 46, Iss. 11, 2007-01 ,pp. : 897-939

Adis International

Access to resources Recommend Favorite

Studies on the metabolism and toxicology of emerging capsinoids

By Watanabe Tatsuo   Ohnuki Koichiro   Kobata Kenji  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 5, 2011-05 ,pp. : 533-542

Informa Healthcare

Access to resources Recommend Favorite

Preclinical studies with new pyrrolidine platinum(II) compounds

By Sampedro F.   van Haperen V.R.   Izquierdo M.   Vicens M.   Santalo P.   Pueyo M.   Llagostera M.   Marcuello E.   De Andres L.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 6, 1995-01 ,pp. : 497-501

Elsevier

Access to resources Recommend Favorite

Is there a gap between preclinical and clinical studies of analgesia?

By Villanueva L.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 461-462

Elsevier

Access to resources Recommend Favorite